210 results on '"Apotheek Klinische Farmacie"'
Search Results
2. Antipsychotic prescribing and drug-related readmissions in multimorbid older inpatients: a post-hoc analysis of the OPERAM population
3. Pharmacists and pharmacy students' perceptions on how a new teaching model supports their clinical decision-making
4. Catching the Culprit: Benzylpenicillin Neurotoxicity Confirmed by Therapeutic Drug Monitoring in a Critically Ill Patient With Continuous Venovenous Hemofiltration
5. Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate
6. A mixed methods analysis of the medication review intervention centered around the use of the ‘Systematic Tool to Reduce Inappropriate Prescribing’ Assistant (STRIPA) in Swiss primary care practices
7. Redispensing of expensive oral anticancer medicines: A practical application
8. Correction to: A mixed methods analysis of the medication review intervention centered around the use of the ‘Systematic Tool to Reduce Inappropriate Prescribing’ Assistant (STRIPA) in Swiss primary care practices (BMC Health Services Research, (2024), 24, 1, (350), 10.1186/s12913-024-10773-y)
9. The impact of patient-reported frailty on cardiovascular outcomes in elderly patients after non-ST-acute coronary syndrome
10. Exploring the pharmacists' role in optimising antithrombotic therapy in primary care: A qualitative study
11. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs
12. Association of Lamotrigine Plasma Concentrations With Efficacy and Toxicity in Patients With Epilepsy: A Retrospective Study
13. Tacrolimus Variability and Clinical Outcomes in the Early Post-lung Transplantation Period: Oral Versus Continuous Intravenous Administration
14. Cognitive processes in pharmacists' clinical decision-making
15. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics
16. Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients
17. Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate
18. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
19. Factors influencing pharmacists' clinical decision making in pharmacy practice
20. Pharmacokinetic investigations of isavuconazole in paediatric cancer patients show reduced exposure of isavuconazole after opening capsules for administration via a nasogastric tube
21. Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between UGT1A1 and irinotecan (European Journal of Human Genetics, (2023), 31, 9, (982-987), 10.1038/s41431-022-01243-2)
22. Dutch pharmacogenetics working group (DPWG) guideline for the gene–drug interaction between UGT1A1 and irinotecan
23. Functional determination of emicizumab in presence of factor VIII activity
24. Pharmacogenetics and phenoconversion: the influence on side effects experienced by psychiatric patients
25. Continuous infusion of cefiderocol in a critically ill patient with continuous venovenous haemofiltration
26. Therapeutic Drug Monitoring of Ganciclovir in Cytomegalovirus-Infected Patients With Solid Organ Transplants and Its Correlation to Efficacy and Toxicity
27. Optimization of a Quantitative Anti-Drug Antibodies against Infliximab Assay with the Liquid Chromatography-Tandem Mass Spectrometry: A Method Validation Study and Future Perspectives
28. Limited excretion of dupilumab into breastmilk: A case report
29. Ion suppression, reduced long-term robustness and leakage current of the spray voltage during the ionization of trichloroacetic acid; a case study with a methylmalonic acid assay
30. Biological Tipping Point in Patients with Atopic Dermatitis Treated with Different Dosing Intervals of Dupilumab
31. High dupilumab levels in tear fluid of atopic dermatitis patients with moderate-to-severe ocular surface disease
32. Association between Genetic Variants and Peripheral Neuropathy in Patients with NSCLC Treated with First-Line Platinum-Based Therapy
33. Combining text mining with clinical decision support in clinical practice: a scoping review
34. Pharmacological protection of the thyroid gland against radiation damage from radioactive iodine labeled compounds in children: a systematic review
35. The association between patient satisfaction with information and adherence to oral anticancer agents
36. Candida keratitis and endopthalmitis after corneal transplantation; two case reports, a novel regimen and literature overview of therapeutic options
37. Antiviral treatment with fluoxetine for rituximab-associated chronic echovirus 13 meningoencephalitis and myofasciitis
38. An easy, fast, and efficient assay for the quantification of peptide Hepcidin-25 in serum and plasma with LC-MS/MS
39. Middle-up quantification of therapeutic monoclonal antibodies in human plasma with two dimensional liquid chromatography high resolution mass spectrometry: Adalimumab as a proof of principle
40. Clinical reasoning by pharmacists: A scoping review
41. Therapeutic drug monitoring of thiopurines: Effect of reduced 6-thioguanine nucleotide target levels in inflammatory bowel disease patients
42. Sequential Stem Cell-Kidney Transplantation in Schimke Immuno-osseous Dysplasia
43. CYP2C19 genotype-guided antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease: study design of a randomized controlled trial (GENPAD)
44. Cost-effectiveness of clopidogrel vs. ticagrelor in patients of 70 years or older with non-ST-elevation acute coronary syndrome
45. Clinical characteristics do not reliably identify non-adherence in patients with uncontrolled hypertension
46. Detectability of Medication Errors With a STOPP/START-Based Medication Review in Older People Prior to a Potentially Preventable Drug-Related Hospital Admission
47. Deprescriptie van psychofarmaca; praktijk en behoeften van patiënten en naasten
48. Medicamenteuze behandeling covid-19 in de tweede lijn
49. Quantification of emicizumab by mass spectrometry in plasma of people with hemophilia A: A method validation study
50. The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.